Four years of clinical experience with Radium-223 for the treatment of castration-resistant prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Four years of clinical experience with Radium-223 for the treatment of castration-resistant prostate cancer

Published:2019-09 Issue:5 Volume:38 Page:298-304
ISSN:2253-8089
Container-title:Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
language:en
Short-container-title:Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

Author:

Álvarez Pérez R.M.,García A. Delgado,Martínez S. García,Viedma S. Sanz,Gerona H. Palacios,Vinardel M. Pajares,García J. M. Jiménez-Hoyuela

Publisher

Elsevier BV

Reference25 articles.

1. REDECAN Working Group Cancer incidence in Spain, 2015;Galceran;Clin Transl Oncol,2017

2. Prostate cancer;Attard;Lancet,2016

3. Effects of skeletal morbidities on longitudinal patient-report outcomes and survival in patients with metastatic prostate cancer;DePuy;Support Care Cancer,2007

4. Prostate Cancer. NCCN Guidelines v3.2016. Web site: http://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf (accessed 21.03.19).

5. Alpha emitter radium-223 and survival in metastatic prostate cancer;Parker;N Engl J Med,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP